Clinical experience with downsized lower energy output implantable cardioverter defibrillators

International Journal of Cardiology

Volumn 66, Issue 3, 1998, Pages 261-266

  Boriani, Giuseppe ^a   Frabetti, Lorenzo ^a   Biffi, Mauro ^a   Sallusti, Luciano ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Guidant Italia   (Italy)

Author keywords

Cardioverter defibrillators; Defibrillation threshold; Ventricular tachyarrhythmias

Indexed keywords

ADULT; AGED; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CONTROLLED STUDY; DEFIBRILLATOR; ENERGY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; STROKE VOLUME; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 0032582607     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(98)00239-3     Document Type: Article

References (21)

1. Sweeney M.O., Ruskin J. Mortality benefits and the implantable cardioverter-defibrillator. Circulation. 89:1994;1851.
2. Bocker D., Block M., Isbruck F.et al. Do patients with an implantable defibrillator live longer? J Am Coll Cardiol. 21:1993;1638-1648.
3. Block M., Hammel D., Bocker D., Borggrefe M., Breithardt G. Drugs or implantable cardioverter- defibrillators in patients with poor left ventricular function? Am J Cardiol. 78(suppl. 5A):1996;62-68.
4. Fogoros R.N. Impact of the implantable cardioverter defibrillator on mortality: The axiom of overall implantable cardioverter defibrillator survival. Am J Cardiol. 78(suppl 5A):1996;57-61.
5. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-83.
6. Moss A.J., Hall W.J., Cannom D.S.et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. New Engl J Med. 335:1996;1933-1944.
7. Mirowski M., Reid P., Mower M.et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. New Engl J Med. 303:1980;322-324.
8. Duffin EG, Barold S, Implantable cardioverter defibrillators: an overview and future directions. In: Singer I, editor, Implantable cardioverter defibrillator. Armonk, Futura, 1994: 751-67.
9. Nisam S. Technology update: the modern implantable cardioverter-defibrillator. Ann Noninvasive Electrocardiol. 1:1997;69-78.
10. Bardy G., Johnson G., Poole J.et al. A simplified, single lead unipolar transvenous cardioversion- defibrillation system. Circulation. 88:1993;543-547.
11. Gold M.R., Sorofsky S.R. Transvenous defibrillation lead systems. J Cardiovasc Electrophys. 7:1996;570-580.
12. Block M, Breithardt G, Long-term follow up and clinical results of implantable cardioverter-defibrillators. In: Zipes DP, Jalife J, editors. Cardiac Electrophisiology. WB Saunders 1995; 1412-25.
13. Austin E., Singer I., Operative techniques for implantation and testing of implantable cardioverter defibrillators. In: Singer I, editor. Implantable cardioverter defibrillator. Armonk, Futura, 1994:327-55.
14. Neuzner J. Safety margins: lessons from the low energy Endotak trial (LEET). Am J Cardiol. 78(suppl 5A):1996;26-32.
15. Klein H., Auricchio A., Huvelle E., Nisam S. Initial clinical experience with a new down-sized implantable cardioverter-defibrillator. Am J Cardiol. 78(suppl. A):1996;9-14.
16. Auricchio A., Klein H. Ventak Mini HC Investigators: Initial experience with the new Ventak Mini HC/Endotak DSP Triad implantable cardioverter defibrillator system. PACE. 19:1996;521.
17. Stanton M.S., Hayes D.L., Munger T.M.et al. Consistent subcutaneous prepectoral implantation of a new implantable cardioverter defibrillator. Mayo Clin Proc. 69:1994;309-314.
18. Fitzpatrick A.P., Lesch M.D., Epstein L.M.et al. Electrophysiological laboratory, electrophysiologist-implanted, non-thoracotomy-implantable cardioverter/defibrillators. Circulation. 89:1994;2503-2508.
19. Jung W., Manz M., Pizzulli L., Pfeiffer D., Luderitz B. Effects of chronic amiodarone therapy on defibrillation threshold. Am J Cardiol. 70:1992;1023-1027.
20. Farrè J., Asso A., Romero J.et al. Antiarrhythmic drugs in patients with an automatic implantable defibrillator. PACE. 18:1995;579-591.
21. Gold M., Foster A., Shorovsky S. Enhanced defibrillation efficacy with an active pulse generator (abstract). J Am Coll Cardiol. Special issue:1995;407A.